コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ith replication in 1,528 participants of the Atherosclerosis Risk in Communities Study.
2 intake, from the biracial, population-based Atherosclerosis Risk in Communities Study.
3 lack and white men and women enrolled in the Atherosclerosis Risk In Communities study.
4 udy of African-American men and women in the Atherosclerosis Risk in Communities Study.
5 were almost 2-fold higher than those in the Atherosclerosis Risk in Communities Study.
6 can-American and white participants from the Atherosclerosis Risk in Communities Study.
7 e authors analyzed prospective data from the Atherosclerosis Risk in Communities Study.
8 d 45-64 y from the Minneapolis center of the Atherosclerosis Risk in Communities Study.
9 ere obtained on 14 219 participants from the Atherosclerosis Risk in Communities Study.
10 an, 45% men) free of AF at baseline from the Atherosclerosis Risk in Communities study.
11 was obtained on 14,200 participants from the Atherosclerosis Risk in Communities Study.
12 a separate sample of 1376 individuals in the Atherosclerosis Risk in Communities Study.
13 ican-American ( n = 908) participants of the Atherosclerosis Risk in Communities study.
14 data from 15,536 adults aged 44-66 yr in the Atherosclerosis Risk in Communities study.
15 sease risk, in 12,491 participants of the US Atherosclerosis Risk in Communities Study.
16 mination (1996-1998) of the population-based Atherosclerosis Risk in Communities Study.
17 phy) among 14,685 middle-aged persons in the Atherosclerosis Risk in Communities Study.
18 e of vitamins C and E in participants of the Atherosclerosis Risk in Communities Study.
19 s free of CHD and heart failure in the ARIC (Atherosclerosis Risk in Communities) study.
20 tein cholesterol (LDL-C) strata in the ARIC (Atherosclerosis Risk in Communities) study.
21 RF improves CHD risk prediction in the ARIC (Atherosclerosis Risk In Communities) study.
22 Japanese American men, and Hispanic men: the Atherosclerosis Risk in Communities Study (1987-1988), P
23 c Cohort Study (1993-2006) (n = 19,529), the Atherosclerosis Risk in Communities Study (1987-1989) (n
24 icipating in the baseline examination of the Atherosclerosis Risk in Communities Study (1987-1989).
25 and COPD in 11,897 US men and women from the Atherosclerosis Risk in Communities study (1987-1989).
26 -aged black and white men and women from the Atherosclerosis Risk in Communities Study (1987-1989).
27 Republic of China Study (1983-1994) and the Atherosclerosis Risk in Communities Study (1987-1998).
28 art disease among 14,480 participants in the Atherosclerosis Risk in Communities Study (1987-1998).
29 n the community-based, multicenter, biracial Atherosclerosis Risk in Communities Study (1987-1999).
30 coronary artery disease using data from the Atherosclerosis Risk in Communities Study (1987-2001).
32 rt of 12,261 middle-aged participants of the Atherosclerosis Risk in Communities Study (1990-1998), w
33 d analysis of 5 longitudinal cohort studies: Atherosclerosis Risk in Communities study, 1990-2006; Ca
34 te dental examinations as part of the Dental-Atherosclerosis Risk in Communities study (1996 to 1998)
35 were classified in 6118 participants in the Atherosclerosis Risk in Communities study (67-91 years o
38 n-American and Caucasian participants in the Atherosclerosis Risk in Communities study, a community-b
39 le-aged African-American participants of the Atherosclerosis Risk in Communities Study, a population-
40 coffee intake and pulmonary function in the Atherosclerosis Risk in Communities Study, a population-
42 cularization) over a 15-year interval in the Atherosclerosis Risk in Communities study according to t
43 artery plaques in 12,773 participants of the Atherosclerosis Risk in Communities Study aged 45-64 y.
44 1 participants (56% women, 26% black) in the Atherosclerosis Risk in Communities Study, aged 52 to 66
45 gene (TTR) in 3856 black participants in the Atherosclerosis Risk in Communities study and assessed c
47 ans of European descent participating in the Atherosclerosis Risk in Communities study and employed a
48 4 years of age prospectively enrolled in the Atherosclerosis Risk in Communities study and free of cl
49 096 nondiabetic participants who were in the Atherosclerosis Risk in Communities study and had normal
50 n cholesterol in European Americans from the Atherosclerosis Risk in Communities Study and in Danes f
51 in 2 prospective observational studies, the Atherosclerosis Risk in Communities Study and the Cardio
52 eart failure from 2 prospective cohorts: the Atherosclerosis Risk in Communities Study and the Cardio
53 nts initially free of clinical stroke in the Atherosclerosis Risk in Communities Study and the Cardio
54 udy combining the 21 860 participants of the Atherosclerosis Risk in Communities study and the Cardio
55 on of 19 295 black and white adults from the Atherosclerosis Risk In Communities Study and the Cardio
56 aseline age 59 years, 43% male) in the ARIC (Atherosclerosis Risk In Communities) study and the CHS (
57 sociation with fasting glucose levels in the Atherosclerosis Risk in Communities Study (ARIC) populat
58 middle-aged participants free of CHD in the Atherosclerosis Risk in Communities Study (ARIC), 725 CH
59 studies: Cardiovascular Health Study (CHS), Atherosclerosis Risk in Communities Study (ARIC), and Mu
60 case-fatality among blacks and whites in the Atherosclerosis Risk in Communities study (ARIC), the Ca
61 ertained VTE from 3 prospective studies: the Atherosclerosis Risk in Communities Study (ARIC), the Ca
62 years; enrollment period, 1989-1994) and the Atherosclerosis Risk in Communities study (ARIC, n = 15,
65 men aged 45-64 years who participated in the Atherosclerosis Risk in Communities Study baseline surve
66 ages 45 to 64 years who participated in the Atherosclerosis Risk in Communities study, beginning in
67 ising 23 608 European-ancestry participants: Atherosclerosis Risk In Communities Study, Cardiovascula
68 nity-based longitudinal studies were pooled: Atherosclerosis Risk in Communities Study, Cardiovascula
69 nity-based longitudinal studies were pooled: Atherosclerosis Risk in Communities Study, Cardiovascula
72 ham Heart Study, Framingham Offspring Study, Atherosclerosis Risk in Communities Study, Chicago Heart
73 Competence Network for Atrial Fibrillation, Atherosclerosis Risk In Communities Study, Cleveland Cli
74 S cohorts included in the meta-analysis [the Atherosclerosis Risk in Communities study cohort (ARIC)
75 Finland Birth Cohort 1966 (NFBC1966) and the Atherosclerosis Risk in Communities study cohort (ARIC).
76 amples were collected and processed from the Atherosclerosis Risk in Communities Study cohort at the
77 tirement on leisure activity using data from Atherosclerosis Risk in Communities Study cohort partici
78 fter 3 years (1990-1992) of follow-up of the Atherosclerosis Risk in Communities Study cohort selecte
79 analyzed data from 3,889 spouse pairs in the Atherosclerosis Risk in Communities Study cohort who wer
81 4,500 spouse pairs aged 45-64 years from the Atherosclerosis Risk in Communities Study cohort, sample
84 individuals from the population-based ARIC (Atherosclerosis Risk In Communities) Study cohort to foc
85 ters) from 6,793 individuals from the Dental Atherosclerosis Risk in Communities Study (DARIC) were u
86 egression analysis of clinical data from the Atherosclerosis Risk in Communities Study demonstrated t
87 ly associated with incident heart failure in Atherosclerosis Risk in Communities Study European Ameri
88 ncestry from the Cardiovascular Heath Study, Atherosclerosis Risk in Communities Study, Framingham Of
89 METHODS AND We analyzed data from the ARIC (Atherosclerosis Risk in Communities) Study Heart Failure
90 without diabetes who were inducted into the Atherosclerosis Risk in Communities study in 1987-1989 a
91 ng 14,082 participants enrolled in the ARIC (Atherosclerosis Risk in Communities) Study initially fre
96 d adults (mean age, 54.1+/-5.8 years) in the Atherosclerosis Risk in Communities Study, Minnesota sub
99 hite men and women aged 45-64 years from the Atherosclerosis Risk in Communities Study (n = 9,267) we
100 cedure was applied to two large cohorts, the Atherosclerosis Risk in Communities Study (N=6617) and t
101 men and women (aged 45 to 64 years) from the Atherosclerosis Risk In Communities study (n=8185) with
103 -sectional study used baseline data from the Atherosclerosis Risk in Communities Study on 11,790 adul
104 ctive longitudinal data (1987-2007) from the Atherosclerosis Risk in Communities Study, our objective
105 growth factor-23 and incident ESRD in 13,448 Atherosclerosis Risk in Communities study participants (
111 omen's Health Initiative clinical trials and Atherosclerosis Risk in Communities Study subpopulations
112 acute or chronic heart failure in the ARIC (Atherosclerosis Risk In Communities) study surveillance
113 4231 participants from 3 CHARGE cohorts: the Atherosclerosis Risk in Communities Study, the Cardiovas
114 etwork, Heart and Vascular Health Study, the Atherosclerosis Risk in Communities Study, the Cleveland
115 tly healthy middle-aged men and women in the Atherosclerosis Risk in Communities study, the relation
116 om the second examination (1990-1992) of the Atherosclerosis Risk in Communities Study to examine IAF
117 as a secondary analysis of the Dental ARIC (Atherosclerosis Risk in Communities) study using serum l
119 Americans and 1,872 African Americans of the Atherosclerosis Risk in Communities study, we performed
123 ,962 middle-aged adults participating in the Atherosclerosis Risk in Communities study were followed
126 pean descent (aged 45-64 years) in the ARIC (Atherosclerosis Risk in Communities) study were followed
127 zing data from 3067 African Americans in the Atherosclerosis Risk in Communities Study who did not ha
128 n and women and White men and women from the Atherosclerosis Risk in Communities Study who were follo
129 rt study conducted among participants in the Atherosclerosis Risk in Communities Study who were free
130 ipants with biracial representation from the Atherosclerosis Risk in Communities Study who were initi
131 study among 1,020 white participants of the Atherosclerosis Risk in Communities Study, whose periodo
132 ong 9051 participants of the community-based Atherosclerosis Risk in Communities Study with no diabet
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。